Avita Medical Reports Q1 Earnings with Revenue Growth and Normalizing Reimbursement Conditions
Avita Medical reported a 4% year-over-year increase in revenue for the first quarter of 2026, reaching $19.3 million—the highest quarterly revenue in over a year—and reaffirmed its full-year guidance between $80 million and $85 million. The company noted improved reimbursement conditions for its RECELL product across all seven Medicare Administrative Contractors, which is helping drive more consistent demand.
Topics: cost_reduction guidance_reaffirmation revenue_growth